A Trial to Evaluate Efficacy of Heart-protecting Musk Pill

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 2700 participants.

Also called NCT01897805

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 2,700 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01897805
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01897805. Randomized; quadruple masking; primary purpose treatment. Start 2011-07 (registry gives no type); primary completion 2015-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Trial to Evaluate Efficacy of Heart-protecting Musk Pill
Intervention (Drug)
Heart-protecting Musk Pill
Intervention (Drug)
Placebo
Lead sponsor
Shanghai Hutchison Pharmaceuticals Limited (class: industry)

Record details

Record id
cardio:ct-nct01897805
Content hash
83d770fd49c86b837d297ff3e61314e908f6bf4b41b84a26ac64cf81d474fa32